- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech Top Stock Picks from Analysts
U.S. Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
518
0 new
Companies which are more than 50% undervalued based on analyst price target.
518 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
BIIB | US$159.83 | 2.5% | -31.1% | US$23.0b | US$251.70 | PE14.4x | E12.4% | n/a | ||
MRNA | US$43.39 | 17.5% | -45.1% | US$16.2b | US$76.36 | PS3.3x | E17.7% | n/a | ||
RPRX | US$26.60 | 1.4% | -1.1% | US$15.5b | US$41.53 | PE10.3x | E6.3% | 3.2% | ||
SMMT | US$18.94 | 1.7% | 871.3% | US$14.2b | US$34.27 | PB31.9x | S85.4% | n/a | ||
PCVX | US$93.98 | 9.3% | 89.1% | US$11.4b | US$151.75 | PB3.4x | E-4.5% | n/a | ||
LEGN | US$43.13 | 7.4% | -27.9% | US$7.8b | US$82.55 | PS15.2x | E70.4% | n/a | ||
CYTK | US$52.22 | 4.7% | 62.5% | US$6.1b | US$81.41 | PS1914.5x | E36.7% | n/a | ||
VKTX | US$54.51 | 5.8% | 360.8% | US$6.0b | US$112.57 | PB6.7x | E-1.8% | n/a | ||
IONS | US$35.90 | 1.4% | -27.3% | US$5.6b | US$61.36 | PS7.1x | E32.9% | n/a | ||
RNA | US$43.33 | -0.7% | 454.8% | US$5.2b | US$68.42 | PS511x | E39.0% | n/a | ||
BBIO | US$27.49 | 19.3% | -3.4% | US$5.0b | US$48.53 | PS23.9x | E26.1% | n/a | ||
RARE | US$48.13 | 3.7% | 23.1% | US$4.4b | US$92.43 | PS8.5x | E54.2% | n/a | ||
CRSP | US$50.84 | 7.6% | -26.4% | US$4.2b | US$81.75 | PS21.4x | E34.5% | n/a | ||
IMVT | US$28.73 | 9.8% | -24.9% | US$4.0b | US$48.93 | PB9.4x | E8.3% | n/a | ||
IBRX | US$5.10 | 4.6% | 28.1% | US$3.6b | US$14.25 | PS484.7x | E72.9% | n/a | ||
DNLI | US$25.16 | 3.0% | 36.8% | US$3.6b | US$42.08 | PB2.7x | E25.6% | n/a | ||
MRUS | US$44.97 | 4.8% | 90.7% | US$3.1b | US$85.64 | PS85.7x | E19.1% | n/a | ||
SWTX | US$41.73 | 11.5% | 55.5% | US$3.1b | US$67.33 | PS22.9x | E70.0% | n/a | ||
DYN | US$31.13 | 3.8% | 183.3% | US$3.0b | US$50.82 | PB4.5x | E2.8% | n/a | ||
FOLD | US$9.96 | 3.9% | -7.4% | US$2.9b | US$17.75 | PS6x | E66.6% | n/a | ||
IOVA | US$9.40 | 15.5% | 65.5% | US$2.8b | US$23.77 | PS31.5x | E67.1% | n/a | ||
ZLAB | US$28.13 | 7.2% | 3.8% | US$2.7b | US$51.81 | PS7.8x | E68.2% | n/a | ||
ACAD | US$16.29 | 0.1% | -26.4% | US$2.7b | US$25.11 | PE21.1x | E26.6% | n/a | ||
ARWR | US$26.15 | 39.8% | -9.8% | US$2.6b | US$45.69 | PS916.4x | E34.1% | n/a |